Proactive Delivery in a Reactive Environment
Kaligia Biosciences is on the forefront of healthcare technology and is developing revolutionary non-invasive point of care devices for the healthcare industry. Our name stems from the Greek word “Kaligia” meaning “good health,” an appropriate name for a company committed to monitoring health and improving patient outcomes.
Kaligia Biosciences
Our Culture
Finding home in the heart of Tampa Bay, Kaligia Biosciences was started in 2015 by a group of entrepreneurs, engineers and visionaries to contribute to the next big evolution in healthcare.
The company is tapping into the power of emerging technologies and creative problem solving to innovate a new breed of biosensors. These devices, which produce quantifiable results with unprecedented speed and accuracy, align with Kaligia’s mission to redefine medical diagnosis and transform healthcare delivery to proactive.
Mission:
To develop innovative in-vitro diagnostic devices for our platform.
Vision:
To change health care delivery to Proactive.
Where We’re Making Change
Kaligia Biosciences
Kaligia Biosciences’s point-of-care devices provide a potential new market for rapid testing in Hospitals, Doctors Offices and Nursing Homes.
Testing in R&D
- Hemoglobin
- Hematocrit
- Glucose
- Creatinine
- Triglycerides
- Cholesterol
- Albumin
- Total Protein
- Viruses
- Methemoglobin
Current Products & Services
- Products, devices and accessories
- Monthly monitoring of patients and collecting data
Use Cases
Hospitals, Medical Facilities and Doctors Offices
Provide more services and timely information to patients – simplifying their experience and allowing their trusted medical professional to provide them with lab results directly.
Nursing Homes
Kaligia’s point-of-care devices offer access to expedited preventative care, avoiding more expensive interventions down the road
Workplace and Educational Institutions
Rapid testing allows for frequent monitoring, allowing for quicker containment and reduced exposure in larger groups.